|
|
|
|
| Advertisement |
 |
|
|
| Advertisement |
Driving compounds forward: Capsugel’s unique combination of drug and process design capabilities – coupled with premier depth in bioavailability enhancement and targeted delivery technologies – enable us to deliver the right solution for challenging compounds. We bring design to the CDMO space.  Learn more
|
|
| Advertisement |
DCAT Week: Business Development—Networking—Education
DCAT Week is the premier global event for the business of pharmaceutical development and manufacturing (March 20-23 in New York City). Organized by the Drug, Chemical & Associated Technologies Association, its unique model brings together members for high-level strategic meetings with key decision makers, timely educational programs and important networking opportunities.  Learn more
|
| Advertisement |
E-Book: A High-Touch Approach to Product Access
Read it Today! Sponsored by AmerisourceBergen
 Learn more
|
| Advertisement |
Pharmaceutical Executive Subscribers Get 20% Off Cold Chain Summit - Canada
With 15th years in the industry, we know your most important pain points, most valuable successes, and the key experts to help you lead your supply chain forward. Our speaking faculty includes McKesson Canada, World Health Organization, Merck, Novartis Pharma Canada, and many more.  Learn more
|
|
| Advertisement |
Regenerative medicine: Overcoming obstacles to reimbursement and market access
Live Webinar: Wednesday, March 8 at 3:00pm EST
 Register now
|
|
| Calendar |
|
|
| Advertisement |
Biologics Manufacturing – Is Your Company Ready?
Live Webinar: Thursday, February 16 at 11:00am EST
 Register now
|
|
|
   |
| Advertisement |
Value-Based Engagement Models: Making Collaborations between Pharma and Health Systems Work
On Demand
 Learn more
|
|
| Industry update |
| //Margaret K. Feltz was named Chief Ethics & Compliance Officer at Purdue Pharma (Stamford, CT).//Retrophin (San Diego, CA) announced William “Bill” Rote, Ph.D. has been appointed Senior Vice President, Research and Development, effective immediately. //The Biotechnology Innovation Organization (BIO) announced that Majority Staff Director of the House Energy and Commerce Committee Dr. Gary Andres, will be joining as Senior Executive Vice President of Public Affairs. //Michael Coleman, Ph.D. has stepped down as President and CEO of InGeneron (Houston, TX). He will join the company’s Scientific Advisory Board. Ron Stubbers, formerly the company’s Vice President of Operations, was appointed President. The company has started the search process for candidates to replace Dr. Coleman as CEO. The company also announced the appointment of Glenn Winnier, Ph.D. as Chief Scientific Officer.// |
| Advertisement |
From Big Data to Measurable Outcomes: Success with Value-Based Contracts
On Demand
 Learn more
|
|
|
